Crispr Therapeutics shares owned by Ark Investment Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Ark Investment Management
from 13F filings
Historical chart of Ark Investment Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Ark Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Ark Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2017-09-30 | $457k | 26k | 17.88 |